Abstract
Single-nucleus RNA-sequencing (snRNA-seq) has revealed new levels of cellular organization and diversity within the human brain. However, full-length mRNA isoforms are not resolved in typical snRNA-seq analyses using short-read sequencing that cannot capture full-length transcripts. Here we combine standard 10X Genomics short-read snRNA-seq with targeted PacBio long-read snRNA-seq to examine isoforms of genes associated with neurological diseases at the single-cell level from prefrontal cortex samples of diseased and non-diseased human brain, assessing over 165,000 cells. Samples from 25 post-mortem donors with Alzheimer’s disease (AD), dementia with Lewy bodies (DLB), or Parkinson’s disease (PD), along with age-matched controls were compared. Analysis of the short-read libraries identified shared and distinct gene expression changes across the diseases. The same libraries were then assayed using enrichment probes to target 50 disease-related genes followed by long-read PacBio sequencing, enabling linkage between cell type and isoform expression. Vast mRNA isoform diversity was observed in all 50 targeted genes, even those that were not differentially expressed in the short-read data. We also developed an informatics method for detection of isoform structural differences in novel isoforms vs. the reference annotation. These data expand available single-cell datasets of the human prefrontal cortical transcriptome with combined short- and long-read sequencing across AD, DLB, and PD, revealing increased mRNA isoform diversity that may contribute to disease features and could potentially represent therapeutic targets for neurodegenerative diseases.
Significance Statement Limited comparisons using single-cell transcriptomics analysis have been conducted amongst common neurodegenerative diseases. Here we identify new cell type and disease relationships involving known and novel mRNA isoforms by profiling single nuclei from human prefrontal cortices of Alzheimer’s disease, Parkinson’s disease, dementia with Lewy bodies and non-diseased controls. Cell-type-specific RNA isoform diversity across the different diseases was examined using the combination of short-read snRNA-seq and targeted long-read single-nucleus isoform sequencing. We identified myriad novel transcripts that highlight an untapped understanding of RNA isoform diversity that exists within the brain and potentially contribute to human neurodegenerative diseases.
Footnotes
This work was in part supported by NIH grants R01 AG071465 and R01AG065541, DoD grant W81XWH-21-10642 and the Bruce Ford and Anne Smith Bundy Foundation and the Larry L. Hillblom Foundation (to J.C); the UC San Diego Cellular and Molecular Pharmacology training grant T32GM007752 (to C.S.L.); and CIRM Postdoctoral Fellowship EDUC4-12813-01 (to T.N.).
We thank Danielle Jones for administrative assistance, Laura Wolszon for sourcing and obtaining human brain specimens, and the Sanford Burnham Prebys Genomics Core for performing RNA integrity number analysis of brain samples. We also express immense gratitude to the donors and families who shared these precious brain materials, of which were obtained from: Emory Alzheimer's Disease Research Center (ADRC) (NIH P50AG025688), NIH NeuroBioBank, Parkinson’s UK Brain Bank [a charity registered in England and Wales (258197) and Scotland (SC037554)], and UC San Diego ADRC (NIH P30AG062429). J.C has an employment relationship with Neurocrine Biosciences, Inc., unrelated to the current work. J.C’s relationship with Neurocrine Biosciences, Inc. has been reviewed and approved by Sanford Burnham Prebys Medical Discovery Institute in accordance with its Conflict-of-Interest Policies.
↵3These authors contributed equally
↵4Lead contact
This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license, which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed.






Jump to comment: